Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Comparison of the 6mg/24hr and 12mg/24hr EMSAM (Selegiline Transdermal System) in Healthy Elderly and Non-Elderly Volunteers

NCT00532116 is registered in ClinicalTrials.gov with Somerset Pharmaceuticals as lead sponsor.

NCT NCT00532116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00532116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Comparison of the 6mg/24hr and 12mg/24hr EMSAM (Selegiline Transdermal System) in Healthy Elderly and Non-Elderly Volunteers
Lead sponsor
Somerset Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
August 31, 2007
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy